Universal Health Services, Inc. (UHS) — Fair Value Analysis

Base-case fair value (P50): $247.98 · Current price: $170.02 · Verdict: Undervalued

The Verdict on UHS

Based on our Monte Carlo simulations, Universal Health Services (UHS) is currently undervalued. With a current price of $170.02, our median fair value (P50) simulation points to $247.98, indicating a substantial +45.9% upside potential. This robust projection suggests a significant discount on the healthcare provider's equity at current market levels, positioning UHS favorably for investors seeking value.

How UHS stacks up against Healthcare

UHS, operating within the critical Healthcare sector, exhibits an average quality tier in terms of its operational and financial health when benchmarked against its industry peers. Despite this average standing, the strong +45.9% identified by our simulations suggests that the market may be undervaluing its future earnings potential more significantly than its quality tier alone might imply. The discrepancy between its $170.02 and the $247.98 fair value highlights a compelling investment opportunity despite its peer-relative quality.

What this means for investors

The analysis strongly suggests that UHS is trading below its intrinsic value. Investors reviewing the current $170.02 should consider the Monte Carlo-derived fair value of $247.98, which forecasts a material +45.9%. This pronounced difference presents an attractive entry point, even for a company with an average quality tier in the Healthcare sector. To fully understand the full bear case and bull case distribution, and to track UHS's fair value as new fundamentals are released, sign up for FairCurve today.